- Compel Capital subsidiary, ScreenPro Security (SCRN) has processed approximately 12,000 tests per week in February
- Weekly revenue over $1.2 million
- ScreenPro provides fast and secure coronavirus screening solutions to the private sector
- Shares of ScreenPro Security trade on the CSE under the symbol SCRN
- ScreenPro opened trading at C$0.12 per share
Compel Capital subsidiary, ScreenPro Security (SCRN) processed approximately 12,000 tests per week in February with weekly revenue of over $1.2 million.
CEO John McMullen stated:
“This has been a very busy time for ScreenPro and I am very pleased for our company to be listed on the CSE. I want to thank all who were involved in making this possible.
Our company processes almost 50,000 screens per month. In February alone, monthly revenue achieved $5 million for testing within the film and television industry in Canada.
Going forward, we are looking to diversify our business into a full suite of pandemic management-related products and services to ensure the safety of the workplace and get people back to work.”
ScreenPro provides fast and secure coronavirus screening solutions to the private sector.
In addition to providing test kits, ScreenPro has access to high-quality PPE to ensure that its clients are protected in all aspects of their testing needs.
Shares of ScreenPro Security trade on the CSE under the symbol SCRN.
ScreenPro Security (SCRN) opened trading at C$0.12 per share.